Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Translingual GTN versus placebo before exercise testing in LVAD recipients with heart failure
ACTRN12623000116628Phase 2Recruiting
- Sponsor
- St Vincent's Hospital Sydney
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nitroglycerin in heart failure (HF) (2 arms), sponsored by St Vincent's Hospital Sydney. Primary endpoints: Difference in peak oxygen consumption and Distance completed during 6-minute walk test. Started Mar 2023; status: recruiting.
02
Drugs
nitroglycerin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ACTRN12623000116628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000116628.